Sushma Swaraj arrives in Saudi Arabia on 3-day visit

Agencies
February 7, 2018

Riyadh, Feb 6: External Affairs Minister Sushma Swaraj today arrived in Riyadh on her maiden visit to Saudi Arabia during which she will inaugurate the Janadriyah festival of the Gulf Kingdom, which is home to over three million Indians.

During the three-day visit, Ms Swaraj will meet with the Saudi leadership and discuss bilateral, regional and global issues of mutual interest.

She will also participate at the inauguration of the prestigious National Heritage and Culture Festival 'Janadriyah', at which India is the guest of honour country.

The festival, organised by the National Guard, exhibits Saudi Arabia's rich tapestry of culture and heritage.

"Warm welcome reflecting our relationship! EAM @SushmaSwaraj received by Saudi officials and Indian Ambassador Ahmad Javed on her arrival at Riyadh airport. Saudi Arabia is India's valued strategic partner," Ministry of External Affairs spokesperson Raveesh Kumar tweeted.

Ms Swaraj will inaugurate the Janadriyah festival on Wednesday.

Minister of State for External Affairs V K Singh had earlier said that India's participation in the festival will be multi-faceted.

"We will have an Indian pavilion where we will project a number of Indian themes and projects. The pavilion will comprise glimpses of traditional and modern India," he said.

Saudi Arabia is home to more than 3 million Indian people and ties between the two countries are on an upswing in the last few years especially after the landmark visit of Prime Minister Narendra Modi to the Gulf Kingdom in April 2016.

Saudi Arabia is India's fourth largest trade partner after China, the US and the UAE. The country is a major source of India's energy requirement as it accounts for almost one- fifth of India's crude oil requirement.

The volume of bilateral trade during 2016-17 was recorded at USD 25.079 billion, a slight decrease from the USD 26.71 billion in 2015-16.  

Comments

Abu Safwan
 - 
Wednesday, 7 Feb 2018

WELCOME MAM..Please try to cancel the new family levy system.  Also inform the Indian School authorities not to increase the school fees for the childrens. Thank you very much

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 7,2020

Belagavi, Mar 7: Karnataka Urban Development Minister B A Basavaraj on Saturday said that government would a take decision very soon regarding conducting city corporations election in the state.

Speaking with the media after review meeting at Belagavi city corporation (BCC) here he further said that delimitation exercise of the wards has to be done followed by reservations.

The minister stated that discussions would be held with Chief Minister B S Yediyurappa and would arrive at a decision to conduct the election in about a month’s time.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
February 28,2020

Mangaluru, Feb 28: Two labourers lost their lives as they were buried alive in a landslip at Karangalpady Junction near Bunts Hostel in the city today.

The landslip occurred when a compound wall collapsed burying at least five persons under the debris. It is feared that three people are still under the debris.

The deceased have been identified as Mohammad Masood (20) from West Bengal and Bhimappa (25) from Bagalkote.

Local police and fire fighters are carrying out rescue operation.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.